Ferrari MD, et al. Sustained Reduction of Migraine Headache Days in Patients With Episodic Migraine During Months 4 to 6 of Treatment With Galcanezumab. IHC-PO-145. IHC 2019, 5-8 sept. Dublin, Ierland.
Bilaterale diepe hersenstimulatie veilig bij parkinsongerelateerde dementie
jan 2018 | Bewegingsstoornissen